| 注册
首页|期刊导航|河北医学|PDD与PTD方案对多发性骨髓瘤患者的疗效及IL-6水平的影响比较

PDD与PTD方案对多发性骨髓瘤患者的疗效及IL-6水平的影响比较

谢玮 庞缨 叶絮 冯莹 李澄宇

河北医学2017,Vol.23Issue(6):882-886,5.
河北医学2017,Vol.23Issue(6):882-886,5.DOI:10.3969/j.issn.1006-6233.2017.06.02

PDD与PTD方案对多发性骨髓瘤患者的疗效及IL-6水平的影响比较

Comparison of the Effects of PDD and PTD and IL-6 Levels in Patients with Multiple Myeloma

谢玮 1庞缨 1叶絮 1冯莹 1李澄宇1

作者信息

  • 1. 广州医科大学第二附属医院血液内科, 广东 广州 510260
  • 折叠

摘要

Abstract

Objective:To study the contrast PDD (Bortezomib + liposome adriamycin + dexamethasone) with PTD (Bortezomib + pirarubicin + dexamethasone) solutions in patients with multiple myeloma curative effect and the influence of the level of IL-6.Methods: From January 2012 to January 2017, Selection of 38 cases of patients with MM.According to the different methods of treatment were divided into PDD group (19 cases), PTD group 19 cases.4 weeks after treatment, respectively observed before and after treatment of the two groups of clinical curative effect, before and after treatment serum levels of IL-6,M protein,tumor cells and β2-microglobulin and adverse reactions occured.Results: The PDD treatment group total remissio rate(sCR+CR) was 31.58% (6/19), compared with PTD group 5.26% (2/19), there''s significant difference (P < 0.05).In the two groups after treatment than before treatment, serum levels of IL-6 and PDD and below the PTD group, and had significant difference (P < 0.05).M protein PDD group after treatment, the tumor cells and β2-microglobulin levels were below the PTD group, and had significant difference (P < 0.05).PDD and PTD group the incidence of hematologic adverse reactions with no significant difference (P > 0.05),but the incidence of alopecia and cardiac toxicity in PDD group was significantly lower than PTD group.Conclusion:The PDD therapy in the treatment of MM had better clinical curative effect, and can effectively improve the patients'' serum level of IL-6,M protein,tumor cells and β2-microglobulin, better security, worthy of clinical popularization and application.

关键词

多发性骨髓瘤/硼替佐米/脂质体阿霉素/地塞米松/白细胞介素-6

Key words

Multiple myeloma/Bortezomib/Liposome adriamycin/Dexamethasone/Interleukin 6

引用本文复制引用

谢玮,庞缨,叶絮,冯莹,李澄宇..PDD与PTD方案对多发性骨髓瘤患者的疗效及IL-6水平的影响比较[J].河北医学,2017,23(6):882-886,5.

基金项目

2013年建设中医药强省立项资助科研课题,(编号:20131262) (编号:20131262)

河北医学

OACSTPCD

1006-6233

访问量0
|
下载量0
段落导航相关论文